Form 4: Longeveron Inc. Executive Nataliya Agafonova Reports Stock Transaction
SEC Form 4
Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., reports disposition of shares to cover tax obligations following a reverse stock split.
Summary
- On May 2, 2024, Nataliya Agafonova, Chief Medical Officer of Longeveron Inc. (LGVN), disposed of 308 shares of Class A Common Stock.
- The transaction was executed at a price of $2.83 per share.
- This disposition was to cover tax obligations.
- Following the transaction, Agafonova directly owns 1,771 shares of Longeveron Inc.
- The reported amounts reflect a one-for-ten reverse stock split undertaken by the Issuer in April 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a routine transaction by an officer to cover tax obligations. It doesn't inherently indicate positive or negative performance for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC for company insiders, providing transparency into their transactions in the company's stock. This particular filing indicates a disposition of shares to cover tax obligations, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| April 2024 | Longeveron Inc. undertook a one-for-ten reverse stock split. |
| 05/02/2024 | Nataliya Agafonova disposed of 308 shares of Class A Common Stock. |
| 05/06/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.